Abbott To Spin Off Hospital Products Unit To Focus On High-Margin Products
This article was originally published in The Tan Sheet
Executive Summary
Abbott Laboratories' Ross consumer health care division will be unaffected by the company's spin-off of its Hospital Products unit, announced Aug. 22
You may also be interested in...
Abbott Builds Up Diabetes Business With TheraSense Acquisition
Access to a development partnership with insulin infusion pump manufacturer Smiths Medical may be a critical component of Abbott Labs' $1.2 bil. purchase of diabetes management firm TheraSense
Abbott Builds Up Diabetes Business With TheraSense Acquisition
Access to a development partnership with insulin infusion pump manufacturer Smiths Medical may be a critical component of Abbott Labs' $1.2 bil. purchase of diabetes management firm TheraSense
Abbott Builds Up Diabetes Business With TheraSense Acquisition
Access to a development partnership with insulin infusion pump manufacturer Smiths Medical may be a critical component of Abbott Labs' $1.2 bil. purchase of diabetes management firm TheraSense